Cost effectiveness of the National HIV/AIDS Strategy goal of increasing linkage to care for HIV-infected persons

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Chaitra GopalappaStephanie L Sansom

Abstract

One of the goals of the National HIV/AIDS Strategy (NHAS) is to increase the proportion of HIV-infected individuals linked to care within 3 months of diagnosis (early linkage) from 65% to 85%. Earlier access to care, and eventually, to treatment, increases life expectancy and quality of life for HIV-infected persons. However, longer treatment is also associated with higher costs, especially for antiretroviral drugs. We evaluated the cost effectiveness of achieving the NHAS goal and estimated the maximum cost that HIV programs could spend on linkage to care and remain cost effective. We used the Progression and Transmission of HIV/AIDS model to estimate the effects on life measures and costs associated with increasing early linkage to care from 65% to 85%. We estimated an incremental cost-effectiveness ratio as the additional cost required to reach the target divided by the quality-adjusted life years (QALYs) gained and assumed that programs costing $100,000 or less per QALY gained are cost effective. Achieving the NHAS linkage-to-care goal increased life expectancy by 0.4 years and delayed the onset of AIDS by 1.2 years on average for every HIV-diagnosed person. Increasing early linkage to care cost an extra $62,200 per QALY ga...Continue Reading

References

Jan 22, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·G Tao, G Remafedi
Aug 18, 2001·Mental Health Services Research·S D PinkertonR G Hoffmann
Dec 6, 2003·The American Journal of Medicine·Sue J GoldieKenneth A Freedberg
Nov 10, 2004·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Ana P Johnson-MasottiSteven D Pinkerton
Feb 11, 2005·The New England Journal of Medicine·Gillian D SandersDouglas K Owens
Feb 11, 2005·The New England Journal of Medicine·A David PaltielRochelle P Walensky
Mar 8, 2005·AIDS·Lytt I GardnerUNKNOWN Antiretroviral Treatment and Access Study Study Group
Nov 30, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kenneth A FreedbergElena Losina
Dec 6, 2006·Annals of Internal Medicine·A David PaltielKenneth A Freedberg
Feb 21, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jason A CrawKarla Schmitt
Mar 20, 2008·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Gregory S ZaricDouglas K Owens
Jun 11, 2008·Archives of Internal Medicine·Lucia V TorianThomas R Frieden
Jul 9, 2008·AIDS Care·M Jean-JacquesK A Freedberg
Nov 8, 2008·Annals of Emergency Medicine·Douglas A E WhiteJames D Heffelfinger
Dec 3, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Vikram S GillP Richard Harrigan
Mar 4, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Edward M GardnerWilliam J Burman
Jul 20, 2011·The New England Journal of Medicine·Myron S CohenUNKNOWN HPTN 052 Study Team
Sep 23, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Michael J MugaveroMichael S Saag
Sep 24, 2011·AIDS Research and Treatment·Kate BuchaczJohn T Brooks

❮ Previous
Next ❯

Citations

Jan 16, 2013·Annals of Internal Medicine·Rochelle P WalenskyBruce R Schackman
Jan 7, 2016·Expert Review of Pharmacoeconomics & Outcomes Research·Tzahit Simon-TuvalDan Greenberg
Dec 15, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rochelle P WalenskyA David Paltiel
Sep 13, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Edward M Gardner
Sep 13, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maunank ShahDavid W Dowdy
Dec 30, 2014·Applied Health Economics and Health Policy·Ya-Lin A HuangStephanie L Sansom
Oct 26, 2013·AIDS Research and Treatment·Anne ZinskiJames L Raper
Nov 6, 2015·Medical Care Research and Review : MCRR·Julia Thornton SniderJohn A Romley
Feb 25, 2015·Medical Care·Bruce R SchackmanElena Losina
Oct 19, 2012·Current Opinion in HIV and AIDS·Bruce R Schackman, Ashley A Eggman
Nov 10, 2017·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Dustin J RabideauRobert A Parker
Nov 23, 2016·AIDS and Behavior·Catherine MaulsbyDavid R Holtgrave
Jan 8, 2020·Open Forum Infectious Diseases·Moses J E FlashEmily P Hyle
Jan 22, 2020·Journal of the International AIDS Society·Ram K ShresthaRobin J MacGowan
Jan 6, 2018·AIDS and Behavior·Catherine MaulsbyUNKNOWN A2C Intervention Team
Apr 17, 2020·Indian Journal of Public Health·Indrani Gupta, Damini Singh
Jan 26, 2021·Sexually Transmitted Diseases·Adrienna BinghamPaul G Farnham
Nov 25, 2021·Mathematical Biosciences and Engineering : MBE·Seyedeh N Khatami, Chaitra Gopalappa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.